Monday, 22 January 2018

BLIS Technology Ordinary Shares

NZX : BLT

0.0190
19 Jan 18 14:43
Change:
 0.00
Open:
0.0180
High:
0.0190
Ask:
0.0190
Volume:
158,240
Change(%):
5.56
Prev:
0.0180
Low:
0.0180
Bid:
0.0180
Avg vol:
0
Profile
BLIS Technologies Limited develops, manufactures, and sells products and ingredients for the oral healthcare market worldwide. The company develops products based on strains of bacteria that produce Bacteriocin-Like Inhibitory Substances (BLIS). Its products include BLIS K12 Throat Guard Daily and BLIS K12 Throat Guard Boost that support throat?s natural defenses against undesirable bacteria; BLIS K12 RapidEze Gargle, which assists the throat?s natural defences by fighting undesirable bacteria associated with winter ill?s and chills; BLIS K12 Travel Guard that supports the throat's natural immune defense system; BLIS Bio Restore, a course of selected intestinal and oral bacteria, which restores and promotes health by restoring the body?s natural microbial balance; and BLIS K12 Fresh Breath Kit for treating chronic bad breath sufferers. The company is based in Dunedin, New Zealand.
Summary
Shares:1,107,654,000
Issuer:BLIS Technologies Limited
Solicitor:Kensington Swan Wellington
Registry:LINK MARKET SERVICES LIMITED
Auditor:Deloitte Dunedin
Settlement:NZCDC Settlement System
Website:http://www.blis.co.nz/
Fundamentals
Market Cap:$21,045,426
52 wk High:0.0530
52 wk Low:0.0150
Sector:Investment
NTA:0.0200
Address
BLIS Technology
Centre for Innovation PO Box 56
87 St David Street
Dunedin, 9016
New Zealand
Latest News
Announcements
  • SPH Notice - WEN Wu (Uob Kay Hian Private Limited)

    10:22 | 30/11/17
    NZX
    Disclosure of ceasing to have substantial holding Section 279, Financial Markets Conduct Act 2013 Note: This form must be completed in accordance with the instructions at the more»
  • SPH Notice - WEN Yi

    10:21 | 30/11/17
    NZX
    Disclosure of beginning to have substantial holding Section 276, Financial Markets Conduct Act 2013 Note: This form must be completed in accordance with the instructions at the more»
  • New distribution partner for NZ Pharmacy channel

    08:34 | 22/11/17
    NZX
    22 November 2017 Blis Technologies announces new distribution partner for NZ Pharmacy channel Blis Technologies is pleased to announce a new agency relationship with Radiant more»
  • BLIS K12 Gains Australian Regulatory Approval

    15:52 | 21/11/17
    NZX
    21 November 2017 BLIS K12 Gains Australian Regulatory Approval Blis Technologies has received notification from the Australian Therapeutic Goods Administration, that its pro more»
  • Half Yearly Report to 30 September 2017

    08:32 | 20/11/17
    NZX
    Blis Technologies Limited- Half Yearly Reports to 30 September 2017. Brian Watson Chief Executive 20 September 2017 End CA:00310603 For:BLT Type:INTERIM Time:2017-11-20 more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
Add a Comment
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
Global Indices
CodeLastChange
NZ508,290170.21%
COMP7,336400.55%
DJI26,072540.21%
SP5002,810120.44%
DAX13,4662361.78%
FTSE7,48850.07%
NI22522,4204081.86%
TWI73.860.140.20%
Currencies
CodeLastChange
EURUSD1.2210.0030.26%
NZDUSD0.72690.00370.51%
AUDUSD0.79870.00240.30%
NZDAUD0.91010.00170.19%